GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microlin Bio Inc (GREY:MICB) » Definitions » YoY EBITDA Growth

Microlin Bio (Microlin Bio) YoY EBITDA Growth : 0.00% (As of Sep. 2015)


View and export this data going back to 2014. Start your Free Trial

What is Microlin Bio YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Microlin Bio's YoY EBITDA Growth for the quarter that ended in Sep. 2015 was 0.00%.

Microlin Bio's EBITDA per Share for the three months ended in Sep. 2015 was $-0.00.

Microlin Bio YoY EBITDA Growth Historical Data

The historical data trend for Microlin Bio's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microlin Bio YoY EBITDA Growth Chart

Microlin Bio Annual Data
Trend Dec12 Dec13 Dec14
YoY EBITDA Growth
- - -922.22

Microlin Bio Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 100.00 -14.29 400.00 - -

Microlin Bio YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Microlin Bio's YoY EBITDA Growth for the fiscal year that ended in Dec. 2014 is calculated as:

YoY EBITDA Growth (A: Dec. 2014 )
=(EBITDA per Share (A: Dec. 2014 )-EBITDA per Share (A: Dec. 2013 ))/ | EBITDA per Share (A: Dec. 2013 ) |
=(-0.092--0.009)/ | -0.009 |
=-922.22 %

Microlin Bio's YoY EBITDA Growth for the quarter that ended in Sep. 2015 is calculated as:

YoY EBITDA Growth (Q: Sep. 2015 )
=(EBITDA per Share (Q: Sep. 2015 )-EBITDA per Share (Q: Sep. 2014 )) / | EBITDA per Share (Q: Sep. 2014 )) |
=(-0.001--0)/ | -0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microlin Bio YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Microlin Bio's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Microlin Bio (Microlin Bio) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microlin Bio Inc (GREY:MICB) » Definitions » YoY EBITDA Growth
Comparable Companies
WAR:PHR TNXP SNGX OSTO:ISR TSX:TRIL XSAT:APTA MIC:LIFE EYEG TSXV:BTI BPMX NVIV LSE:AOR SNBP TSXV:HXI TSX:MDNA TSXV:HEM WAR:BML MYMX OSL:SOFTOX-ME TSX:CTX
Traded in Other Exchanges
N/A
Address
Website
http://www.microlinbio.com
MicroLin Bio Inc is engaged in the healthcare sector. It is a therapeutic and diagnostic company focusing on microRNA and its role in oncology. MicroRNAs represent a class of diagnostics and therapeutics that are more effective in the diagnosis and treatment of cancer, with the potential for mitigating side effects in comparison with conventional small molecule drugs or biologics. The company's properties include molecular diagnostics and companion tests, cancer therapeutics, and delivery platform technology. Molecular diagnostics & companion tests include tests such as Lumira, Omira, Colomira, and Promira. Cancer therapeutics includes lumiralin, omiralin, colomiralin, and promirali.

Microlin Bio (Microlin Bio) Headlines

No Headlines